Viewing Study NCT06306079



Ignite Creation Date: 2024-05-06 @ 8:14 PM
Last Modification Date: 2024-10-26 @ 3:23 PM
Study NCT ID: NCT06306079
Status: COMPLETED
Last Update Posted: 2024-03-12
First Post: 2022-12-31

Brief Title: Using Gait Modification to Treat Knee Osteoarthritis in Saudi Arabia Possibilities and Acceptability
Sponsor: King Khalid University
Organization: King Khalid University

Study Overview

Official Title: The Possibilities and Acceptability of Applying Gait Modification to the Treatment of Knee Osteoarthritis in Saudi Arabia Based on the Perceptions of Patients and Physiotherapists A Mixed-methods Feasibility Study
Status: COMPLETED
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: A variety of biomechanical gait modification interventions can elevate knee loading and improve knee symptoms in knee osteoarthritis patients However there was a lack of acceptability and adherence regarding modification interventions without any explanation

Thus this study investigates the feasibility and acceptability of foot insoles as a gait modification tool among Saudi Arabian knee osteoarthritis patients and physiotherapists

This study aims to answer the following

Which gait modification intervention is most likely to be implemented in Saudi Arabia SA clinical practice taking context patients clinical and research evidence into consideration
In Saudi Arabia can this proposed foot-insole intervention be implemented Is there sufficient experience among physiotherapists regarding gait modification to deliver it and will patients engage with it How can KOA rehabilitation outcomes be evaluated in the future

The participants will be conducted over three phases

1 The patients interview and therapists focus group discussion will be used to examine KOA patients and clinicians perspectives on enabling and accepting gait modifications in phase 1
2 The feasibility study will explore how a small number of KOA patients tolerate gait modifications and consider the most relevant outcome measures such as pain and function in phase 2
3 A small group of knee osteoarthritis patients and their physiotherapists who participated in phase 2 will be asked to participate in a descriptive survey in phase 3 To examine the acceptability and feasibility of the study intervention in phase 2
Detailed Description: Since several different types of gait modifications have been studied it has been challenging to determine which are most likely to be used by patients and healthcare professionals

A notable number of Saudi Arabians suffer from knee osteoarthritis KOA which reported a 295 prevalence of KOA another recent study reported a 245 prevalence of KOA among the elderly A 2002 study found that 308 of those aged 46-55 and 606 aged 66-75 were affected Thus KOA is roughly equally distributed between genders and is more prevalent among elderly and overweight individuals so policymakers should focus on raising awareness to prevent and treat affected individuals The healthcare system in SA is publicly funded and accessible 79 of patients use the public system and the rest obtain private care In most cases private patients have insurance coverage The public healthcare system has three primary secondary and tertiary care levels Rehabilitation and gait modification investigations are not available at the primary level

This snapshot of the literary review raises questions about the viability of the long-term use of learnedassistive gait modifications The studies reported dissatisfaction with the gait modification approach but gave no reasons Since most studies focus on results in a short time or a specific area pre-training courses measuring acceptability and commitment can fill the gaps in previous studies After determining the importance of gait modification the question becomes should it be integrated into the therapy strategy or other rehabilitative methods to increase the treatments clinical efficacy It is essential to understand the practices views and expectations of KOA patients and health professionals concerning gait modifications

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
Abdullah Al Assiri OTHER None None
Prof Pip Logan OTHER None None
Professor Ana Valdes OTHER None None
Dr Benjamin Smith OTHER Doctor of Physiotherapy Division of Rehabilitation and Ageing University of Nottingham UK None